IP Library Assignment 048148/0736
Patent Assignment
Reel/Frame 048148/0736

Assignment of Assignor's Interest

Recorded: 2018-11-20 Pages: 6
Assignor
ZENITH CAPITAL CORP.
Executed: 2016-11-21
Assignee
ZENITH EPIGENETICS LTD.
300,4820 RICHARD ROAD SW, CALGARY, AB, T3E 6L1, CANADA
Covered Property (1)
Novel Bicyclic Bromodomain Inhibitors
Application: 15/875,678 →
Publication: US 2018/0161337
Related Assignments (4)
Other recorded transfers of the patent in this record — the chain of ownership.
Assignment of Assignor's Interest Nov 20, 2018
From: QUINN, JOHN FREDERICK; DUFFY, BRYAN CORDELL; LIU, SHUANG; WANG, RUIFANG
To: RVX THERAPEUTICS INC.
Reel/Frame 047552/0613 →
General Conveyance and Assumption Agreement Nov 20, 2018
From: RVX THERAPEUTICS INC.
To: ZENITH EPIGENETICS CORP,
Reel/Frame 047605/0756 →
Assignment of Assignor's Interest Nov 20, 2018
From: QUINN, JOHN FREDERICK; DUFFY, BRYAN CORDELL; LIU, SHUANG; WANG, RUIFANG
To: ZENITH EPIGENETICS CORP.
Reel/Frame 047605/0785 →
Change of Name Nov 20, 2018
From: ZENITH EPIGENETICS CORP.
To: ZENITH CAPITAL CORP.
Reel/Frame 048148/0718 →